Filing Details

Accession Number:
0001104659-14-018532
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-11 19:28:35
Reporting Period:
2014-03-07
Filing Date:
2014-03-11
Accepted Time:
2014-03-11 19:28:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1544227 Ovascience Inc. OVAS Pharmaceutical Preparations (2834) 451472564
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1551614 Michelle Dipp C/O Ovascience, Inc.
215 First Street, Suite 240
Cambridge MA 02142
President & Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-03-07 100,000 $10.00 3,820,571 No 4 P Indirect By Longwood Fund, LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Longwood Fund, LP
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 822,274 Direct
Footnotes
  1. Represents 758,171 shares of common stock and 64,103 RSUs.
  2. Longwood Fund GP, LLC is the general partner of Longwood Fund, LP. Voting and investment power with respect to the shares held by Longwood Fund, LP are vested in the Reporting Person, Richard Aldrich and Christoph Westphal, M.D., Ph.D. (collectively, the "Managers"), the managers of Longwood Fund GP, LLC. Each of the Managers disclaims beneficial ownership of the shares held by Longwood Fund, LP, except to the extent of their respective pecuniary interest therein, and the inclusion of these shares in the report shall not be deemed an admission of beneficial ownership of the shares for the purposes of Section 16 or for any other purpose.